One-year outcomes in cardiogenic shock triggered by supraventricular tachycardia: an analysis of the FRENSHOCK multicenter prospective registry - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Frontiers in Cardiovascular Medicine Année : 2023

One-year outcomes in cardiogenic shock triggered by supraventricular tachycardia: an analysis of the FRENSHOCK multicenter prospective registry

Eric Bonnefoy
  • Fonction : Auteur
Bruno Levy
  • Fonction : Auteur
Sebastien Champion
  • Fonction : Auteur
Francis Schneider
  • Fonction : Auteur
Hadi Khachab
  • Fonction : Auteur
Marie-France Seronde
  • Fonction : Auteur
Guillaume Schurtz
  • Fonction : Auteur
Gerald Vanzetto
  • Fonction : Auteur
Nicolas Combaret
  • Fonction : Auteur
Vincent Labbe
  • Fonction : Auteur
Benjamin Marchandot
  • Fonction : Auteur
Benoit Lattuca
  • Fonction : Auteur
Caroline Biendel-Picquet
  • Fonction : Auteur

Résumé

Background Cardiogenic shock (CS) is the most severe form of heart failure (HF), resulting in high early and long-term mortality. Characteristics of CS secondary to supraventricular tachycardia (SVT) are poorly reported. Based on a large registry of unselected CS, we aimed to compare 1-year outcomes between SVT-triggered and non-SVT-triggered CS.Methods FRENSHOCK is a French prospective registry including 772 CS patients from 49 centers. For each patient, the investigator could report 1–3 CS triggers from a pre-established list (ischemic, mechanical complications, ventricular/supraventricular arrhythmia, bradycardia, iatrogenesis, infection, non-compliance, and others). In this study, 1-year outcomes [rehospitalizations, mortality, heart transplantation (HTx), ventricular assist devices (VAD)] were analyzed and adjusted for independent predictive factors.Results Among 769 CS patients included, 100 were SVT-triggered (13%), of which 65 had SVT as an exclusive trigger (8.5%). SVT-triggered CS patients exhibited a higher proportion of male individuals with a more frequent history of cardiomyopathy or chronic kidney disease and more profound CS (biventricular failure and multiorgan failure). At 1 year, there was no difference in all-cause mortality (43% vs. 45.3%, adjusted HR 0.9 (95% CI 0.59–1.39), p = 0.64), need for HTx or VAD [10% vs. 10%, aOR 0.88 (0.41–1.88), p = 0.74], or rehospitalizations [49.4% vs. 44.4%, aOR 1.24 (0.78–1.98), p = 0.36]. Patients with SVT as an exclusive trigger presented more 1-year rehospitalizations [52.8% vs. 43.3%, aOR 3.74 (1.05–10.5), p = 0.01].Conclusion SVT is a frequent trigger of CS alone or in association in more than 10% of miscellaneous CS cases. Although SVT-triggered CS patients were more comorbid with more pre-existing cardiomyopathies and HF incidences, they presented similar rates of mortality, HTx, and VAD at 1 year, arguing for a better overall prognosis. Clinical Trial Registration https://clinicaltrials.gov , identifier: NCT02703038.
Fichier principal
Vignette du fichier
2023 Cherbi et al., One.pdf (1.02 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-04214552 , version 1 (22-09-2023)

Identifiants

Citer

Miloud Cherbi, Eric Bonnefoy, Nicolas Lamblin, Edouard Gerbaud, Laurent Bonello, et al.. One-year outcomes in cardiogenic shock triggered by supraventricular tachycardia: an analysis of the FRENSHOCK multicenter prospective registry. Frontiers in Cardiovascular Medicine, 2023, 10, ⟨10.3389/fcvm.2023.1167738⟩. ⟨hal-04214552⟩
33 Consultations
15 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More